Septodont and Dentroid Enter a Global Development and Commercialization Partnership to Pioneer Non-invasive Pain Management in Dentistry
Saint-Maur-des-Fossés, France and Canberra, Australia – May 2026 – Septodont, the global leader in dental pain management, and Dentroid, a pioneering Australian medtech startup , today announced that they have entered into a global development and commercialization partnership to deliver innovative solutions designed to redefine pain management, address dental anxiety and enhance both the dentist and patient experience.
Pain is more than a symptom, it can be a barrier to trust, comfort, and care in clinical settings. Through their partnership, Septodont and Dentroid will combine complementary expertise to develop sustainable, innovative and non-invasive solutions that will redefine the standard of pain management in dentistry and address some of the root causes behind dental anxiety. This will lead to improved oral healthcare outcomes and, ultimately, better overall health and wellbeing.
Under the landmark agreement, Septodont and Dentroid will join forces on the development pathway and global commercialization plans for Dentroid’s patented Nuralyte® technology. This will see the realization of a shared vision; a friendlier, non-invasive and comfortable patient experience, achieved by supporting dental professionals with gentler solutions that simplify everyday practice workflows.
“Septodont’s mission is to make pain-free dentistry possible. We believe innovation plays an important role when it is truly customer centric. We are excited to partner with Dentroid to help us bring to market solutions that will make a real difference for dentists and patients” said Todd Beechey, Chief Financial & Strategy Officer Septodont.
“Dentroid is all about addressing the root cause of dental pain and anxiety—needles, drills or sprays. We could not ask for a better partner than Septodont; the global leader of pain management solutions in dentistry for more than 90 years! It is an incredibly exciting moment for both companies, if not for the dental profession at large, and we look forward to redefining the standards of care together”. Said Dr Omar Zuaiter, dentist, cofounder and CEO of Dentroid.
About Septodont
Septodont, global leader in dental pain management, develops, manufactures and distributes a wide range of high-quality dental and medical solutions that support clinicians in everyday practice. Septodont has an established presence in more than 120 countries through subsidiaries and a strong distribution network. Every second, approximately 30 anesthetic cartridges manufactured by Septodont are injected worldwide. Learn more about Septodont’s innovative products and solutions at https://www.septodontcorp.com.
About Dentroid
Dentroid is a pioneering dental and medtech startup founded in 2017 in the Australian Capital Territory. By harnessing photonics and robotics, Dentroid is on a mission to redefine dentistry (and beyond) via gentle solutions that address the enduring pain of needles, drills and sprays.
